NZYM B Novozymes A/S Class B

Resolutions from the Annual General Meeting 2025

Resolutions from the Annual General Meeting 2025

Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted.

 The following resolutions were made:

  • Approval of the audited Annual Report for 2024
  • Approval of distribution of profit with payment of an ordinary dividend of DKK 4.20 (corresponding to approximately EUR 0.56) per A and B share. In addition to this year-end dividend, an interim dividend of DKK 2.00 (EUR ~0.27) was disbursed on September 3, 2024.
  • Approval of the Remuneration Report for 2024 (advisory vote)
  • Approval of the remuneration of members of the Board of Directors for 2025
  • Re-election of Cornelis (Cees) de Jong as Chair of the Board of Directors
  • Re-election of Heine Dalsgaard as a member of the Board of Directors and election as new Vice Chair
  • Re-election of Lise Kaae, Kasim Kutay, Kevin Lane, Morten Otto Alexander Sommer, and Kim Stratton as members of the Board of Directors
  • Election of Monila Kothari as a new member of the Board of Directors
  • Re-election of EY Godkendt Revisionspartnerselskab as the company’s auditors in respect of statutory financial and sustainability reporting
  • Approval to renew the authorizations to the Board of Directors to implement capital increases
  • Approval to renew the authorization to the Board of Directors to acquire treasury shares
  • Approval of the authorization to the Board of Directors to distribute extraordinary dividends



Composition of the Board of Directors and its committees

After the Annual General Meeting, the Board of Directors held a board meeting to appoint members of its committees.

The Board of Directors, including its committees, is now composed as follows:

  • Cees (Cornelis) de Jong (Chair of the Board, chair of the Nomination and Remuneration Committee and member of the Audit Committee)
  • Heine Dalsgaard (Vice Chair of the Board and member of the Audit Committee)
  • Robert Nøddeskov Jensen (employee representative)
  • Lise Kaae (chair of the Audit Committee)
  • Monila Kothari (member of the Innovation Committee)
  • Kasim Kutay (member of the Nomination and Remuneration Committee)
  • Lars Bo Køppler (employee representative)
  • Kevin Lane (member of the Innovation Committee)
  • Preben Nielsen (employee representative and member of the Innovation Committee)
  • Frederikke Rose Spenner (employee representative)
  • Morten Otto Alexander Sommer (chair of the Innovation Committee)
  • Kim Stratton (member of the Nomination and Remuneration Committee)

For further information on the members of the Board of Directors, please go to

Attachment



EN
03/04/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Novozymes A/S Class B

 PRESS RELEASE

Novonesis Hosts National Flagship Manufacturing Day Event at North Ame...

Novonesis Hosts National Flagship Manufacturing Day Event at North America Headquarters Franklinton, NC, Oct. 06, 2025 (GLOBE NEWSWIRE) -- , a global leader in biosolutions, welcomed hundreds of local students, educators, and community leaders to its facilities in Salem, Virginia; West Allis and Madison, Wisconsin; and its North American headquarters in Franklinton, North Carolina, for the national flagship (MFG Day), a grassroots movement of the (MI). The MI is the workforce development and education affiliate of (NAM). The MI’s mission is to build and strengthen the manufacturing workfo...

 PRESS RELEASE

Major shareholder announcement

Major shareholder announcement Please read the full announcement in PDF Attachments

 PRESS RELEASE

Novonesis and Novo Nordisk will explore new solutions to improve metab...

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health Novonesis and Novo Nordisk join forces in a new research collaboration to explore solutions that seek to preserve and optimize metabolic health and well-being for people. COPENHAGEN, Denmark – September 8, 2025. Novonesis and Novo Nordisk has entered a research partnership to explore the role of the gut microbiome in the maintenance of metabolic health. The gut microbiome is the collection of microorganisms, such as bacteria, fungi, and viruses, that naturally live in the human gut. The science...

 PRESS RELEASE

Trading by management and close relations of management

Trading by management and close relations of management Please read the announcement in PDF Attachment

 PRESS RELEASE

Amendment: Trading by management and close relations of management

Amendment: Trading by management and close relations of management Please read the announcement in PDF Attachment

ResearchPool Subscriptions

Get the most out of your insights

Get in touch